欢迎来到《四川大学学报(医学版)》

基于罗马Ⅳ标准的中国高校学生功能性消化不良和肠易激综合征现况调查

高旭 刘娜 郝宇杰 张晓辉 杨倩 蒋潇洒 刘奕辛 蔡雅琴 宋萍 纪泛扑 王进海

高旭, 刘娜, 郝宇杰, 等. 基于罗马Ⅳ标准的中国高校学生功能性消化不良和肠易激综合征现况调查[J]. 四川大学学报(医学版), 2023, 54(3): 574-578. doi: 10.12182/20230560208
引用本文: 高旭, 刘娜, 郝宇杰, 等. 基于罗马Ⅳ标准的中国高校学生功能性消化不良和肠易激综合征现况调查[J]. 四川大学学报(医学版), 2023, 54(3): 574-578. doi: 10.12182/20230560208
GAO Xu, LIU Na, HAO Yu-jie, et al. Prevalence Survey of Functional Dyspepsia and Irritable Bowel Syndrome in Chinese College Students Based on Rome Ⅳ Diagnostic Criteria[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2023, 54(3): 574-578. doi: 10.12182/20230560208
Citation: GAO Xu, LIU Na, HAO Yu-jie, et al. Prevalence Survey of Functional Dyspepsia and Irritable Bowel Syndrome in Chinese College Students Based on Rome Ⅳ Diagnostic Criteria[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2023, 54(3): 574-578. doi: 10.12182/20230560208

基于罗马Ⅳ标准的中国高校学生功能性消化不良和肠易激综合征现况调查

doi: 10.12182/20230560208
基金项目: 陕西省重点研发计划(No. 2017ZDXM-SF046)资助
详细信息
    通讯作者:

    E-mail:jinhaiwang@hotmail.com

Prevalence Survey of Functional Dyspepsia and Irritable Bowel Syndrome in Chinese College Students Based on Rome Ⅳ Diagnostic Criteria

More Information
  • 摘要:   目的  了解我国高校学生功能性消化不良(functional dyspepsia, FD)、肠易激综合征(irritable bowel syndrome, IBS)的患病率及危险因素。  方法  本研究采用网络电子问卷为主联合现场调查为辅的调查方法,对17~35岁之间的中国各地高校学生进行在线问卷调查, 最终纳入2025份有效问卷进行统计分析。统计学方法采用χ2检验和logistic回归。  结果  符合罗马Ⅳ标准高校学生FD患病率为5.5%(112/2025),以餐后不适综合征(postprandial distress syndrome, PDS)(66.1%,74/112)为主,吸烟〔比值比(OR)=2.334,95%置信区间(CI):1.187~4.589, P=0.014〕、抑郁(OR=2.447,95%CI:1.421~4.214, P=0.001)、失眠(OR=1.947,95%CI:1.291~2.937, P=0.001)与FD患病呈正相关。IBS患病率为1.9%(38/2025),以腹泻型(diarrhea-predominant IBS, IBS-D)为主(44.7%),焦虑(OR=3.63,95%CI:1.34~9.88,P=0.012)、失眠(OR=2.35,95%CI:1.18~4.68, P=0.015)与IBS患病呈正相关。  结论  基于罗马Ⅳ标准,IBS、FD在中国高校学生中患病并不少见,心理障碍和一些相关的生活方式因素可能与疾病发展有关,未来应该在中国开展更多基于不同诊断标准、不同地域、多因素的系列研究。
  • 表  1  FD、IBS的患病情况调查结果(单选题)

    Table  1.   Results for FD and IBS prevalence survey (single-choice questions)

    Factor Variable Non-FD group
    (n=1913)
    FD group
    (n=112)
    P Non-IBS group
    (n=1987)
    IBS group
    (n=38)
    P
    Sex Male 690 43 0.619 716 17 0.269
    Female 1223 69 1271 21
    Age/yr. 17-23 1196 65 0.306 1231 30 0.090
    24-29 683 43 718 8
    30-35 34 4 38 0
    BMI Underweight 314 12 0.311 324 2 0.127
    Normal 1397 84 1452 29
    Overweight 191 15 199 7
    Obesity 11 1 12 0
    Grade First year 204 10 0.243 208 6 0.799
    Second year 256 14 265 5
    Third year 281 12 287 6
    Fourth year 256 24 273 7
    Fifth year 115 10 124 1
    Master's student 677 37 702 12
    Doctoral student 124 5 128 1
    Major Economics and management 193 11 0.259 201 3 0.170
    Science and engineering 469 27 489 7
    Literature and history 93 1 92 2
    Politics and law 61 2 63 0
    Arts 26 3 27 2
    Sports 16 3 17 2
    Languages 25 2 26 1
    Medicine 997 62 1040 19
    Agriculture 33 1 32 2
    Being the only child of the family No 1168 64 0.410 1214 18 0.086
    Yes 745 48 773 20
    Smoking No 1835 101 0.008 1899 37 0.892
    Yes 78 11 88 1
    Drinking No 1788 97 0.005 1849 36 0.935
    Yes 125 15 138 2
    Regular mealtime Very regular 332 11 0.017 336 7 0.886
    More regular 1200 68 1243 25
    Regular 157 17 171 3
    Irregular 224 16 237 3
    Breakfast frequency Daily 838 43 0.279 867 14 0.215
    4-6 times/week 550 38 572 16
    1-3 times/week 442 23 457 8
    Always skipping breakfast 83 8 91 0
    Dietary attitude Taste first 536 26 0.051 550 12 0.883
    Satiety first 293 27 313 7
    Nutrition first 340 14 348 6
    Occasional balanced diet 744 45 776 13
    Mobile phone addiction No 455 13 0.003 467 1 0.003
    Yes 1458 99 1520 37
    Anxiety No 967 32 0.000 994 5 0.000
    Yes 946 80 993 33
    Depression No 722 18 0.000 736 4 0.001
    Yes 1191 94 1251 34
    Insomnia No 1280 52 0.000 1323 9 0.000
    Yes 633 60 664 29
    下载: 导出CSV

    表  2  FD、IBS的患病情况调查结果(多选题)

    Table  2.   Results for FD and IBS prevalence survey (multiple-choice questions)

    Factor Variable Non-FD group (n=1913) FD group (n=112) P Non-IBS group (n=1987) IBS group (n=38) P
    Beverage preferences Bubble tea 616 39 0.186 641 14 0.847
    Fruit juices 740 46 772 14
    Coffee 285 21 298 8
    Carbonated drinks 501 32 520 13
    Water 1187 56 1218 25
    Tea 486 34 509 11
    Milk or yogurt 456 28 474 10
    Dietary preferences Uncooked or unheated food 213 22 0.001 231 4 0.635
    Spicy food 967 65 1010 22
    Deep-fried food 535 47 567 15
    Cheese 709 47 742 14
    Fruit 1308 75 1360 23
    Vegetable 1237 68 1282 23
    Source of stress Family 836 56 0.614 876 16 0.874
    Interpersonal relations 788 47 821 14
    Career 850 55 891 14
    Studies 1554 94 1618 30
    Romantic relationship 382 23 399 6
    Personal health 736 47 769 14
    Mood 953 63 996 20
    Adaptation 474 32 500 6
    下载: 导出CSV
  • [1] AZIZ I, PALSSON O S, TÖRNBLOM H, et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome Ⅳ functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol,2018,3(4): 252–262. doi: 10.1016/S2468-1253(18)30003-7
    [2] OKA P, PARR H, BARBERIO B, et al. Global prevalence of irritable bowel syndrome according to Rome Ⅲ or Ⅳ criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol,2020,5(10): 908–917. doi: 10.1016/S2468-1253(20)30217-X
    [3] ALBUTAYSH O F, ALQURAINI A A, ALMUKHAITAH A A, et al. Epidemiology of irritable bowel syndrome and its associated factors in Saudi undergraduate students. Saudi J Gastroenterol,2020,26(2): 89–93. doi: 10.4103/sjg.SJG_459_19
    [4] YANG W, YANG X, CAI X, et al. The Prevalence of irritable bowel syndrome among Chinese university students: a systematic review and meta-analysis. Front Public Health,2022,10: 864721. doi: 10.3389/fpubh.2022.864721
    [5] CARBONE F, VANUYTSEL T, TACK J. Analysis of postprandial symptom patterns in subgroups of patients with Rome Ⅲ or Rome Ⅳ functional dyspepsia. Clin Gastroenterol Hepatol,2020,18(4): 838–846.e3. doi: 10.1016/j.cgh.2019.07.053
    [6] FORD A C, MARWAHA A, SOOD R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut,2015,64(7): 1049–1057. doi: 10.1136/gutjnl-2014-307843
    [7] TALLEY N J, POWELL N, WALKER M M, et al. Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population-based studies. Aliment Pharmacol Ther,2021,54(1): 32–42. doi: 10.1111/apt.16372
    [8] STEC-MICHALSKA K, PECZEK L, MICHALSKI B, et al. Influence of cigarette smoking on the level of mRNA of somatostatin receptor 3 (SSTR3) in the gastric mucosa of patients with functional dyspepsia. Adv Med Sci,2010,55(1): 53–58. doi: 10.2478/v10039-010-0026-3
    [9] SINGH P, BALLOU S, RANGAN V, et al. Clinical and psychological factors predict outcome in patients with functional dyspepsia: a prospective study. Clin Gastroenterol Hepatol,2022,20(6): 1251–1258.e1. doi: 10.1016/j.cgh.2021.07.043
    [10] WUESTENBERGHS F, MELCHIOR C, DESPREZ C, et al. Sleep quality and insomnia are associated with quality of life in functional dyspepsia. Front Neurosci,2022,16: 829916. doi: 10.3389/fnins.2022.829916
    [11] YAMAMOTO Y, FURUKAWA S, WATANABE J, et al. Positive Association Between Sleep Disturbance and Prevalence of Functional Dyspepsia in Japanese Young People. Dig Dis Sci,2022,67(8): 3929–3937. doi: 10.1007/s10620-021-07260-3
    [12] DONG Y Y, ZUO X L, LI C Q, et al. Prevalence of irritable bowel syndrome in Chinese college and university students assessed using Rome Ⅲ criteria. World J Gastroenterol,2010,16(33): 4221–4226. doi: 10.3748/wjg.v16.i33.4221
    [13] SIMRÉN M, TACK J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol,2018,15(10): 589–605. doi: 10.1038/s41575-018-0034-5
    [14] TANG H, CHEN X, HUANG S, et al. Targeting the gut-microbiota-brain axis in irritable bowel disease to improve cognitive function—recent knowledge and emerging therapeutic opportunities. Rev Neurosci,2023. doi: 10.1515/revneuro-2022-0155
    [15] ISLAM Z, D'SILVA A, RAMAN M, et al. The role of mind body interventions in the treatment of irritable bowel syndrome and fibromyalgia. Front Psychiatry,2022,13: 1076763. doi: 10.3389/fpsyt.2022.1076763
  • 加载中
表(2)
计量
  • 文章访问数:  17
  • HTML全文浏览量:  5
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-08-29
  • 修回日期:  2023-04-16
  • 网络出版日期:  2023-05-20
  • 刊出日期:  2023-05-20

目录

    /

    返回文章
    返回